MedPath
FDA Approval

Haemonetics Anticoagulant Sodium Citrate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
February 2, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Gadofosveset trisodium(40 mg in 1 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Haemonetics Anticoagulant Sodium Citrate

Product Details

NDC Product Code
57826-420
Application Number
BN980123
Marketing Category
NDA (C73594)
Route of Administration
EXTRACORPOREAL
Effective Date
February 2, 2021
WATERInactive
Code: 059QF0KO0RClass: IACT
Code: B22547B95KClass: ACTIMQuantity: 40 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath